Description

9-Me-BC Powder

9-Me-BC
CAS Number	2521-07-5
Molar Mass	182.226 g·mol−1
Chemical Structure	C12H10N2
IUPAC Name	5-Methyl-5H-pyrido[3,4-b]indole

Introduction

9-ME-BC Powder is a research compound specifically designed for research purposes, and it is not intended for human consumption. This compound has emerged as a valuable tool within the scientific community due to its potential neurobiological benefits and applications. Researchers have increasingly turned to 9-ME-BC Powder to explore its effects on neuroprotection, cognitive function, and neuroplasticity.

Key Characteristics

9-ME-BC Powder, or 9-methyl-β-carboline in powdered form, is characterized by its unique capacity to interact with the brain-derived neurotrophic factor (BDNF) signaling pathway. This interaction has sparked interest among researchers focusing on its influence on neuroprotection, cognitive enhancement, and neural plasticity.

Research Applications

9-ME-BC Powder has found applications in a range of research endeavors, primarily in the fields of neuroscience and neuropharmacology. Researchers have harnessed its properties to study neuroprotection, cognitive function, and neural plasticity. Its potential applications span research on neurodegenerative diseases and cognitive disorders.

Research Benefits

Cognitive Enhancement

Studies have demonstrated that 9-ME-BC Powder has the potential to enhance cognitive functions, especially memory and learning. This benefit holds substantial promise for research in the context of cognitive disorders and conditions associated with memory impairment.

Neuroprotection

9-ME-BC Powder displays neuroprotective properties, positioning it as a valuable asset in research concerning neurodegenerative diseases. It exhibits the potential to safeguard neurons from damage, contributing to the overall health of neural tissues.

Neural Plasticity

The compound has shown the potential to facilitate neural plasticity, a fundamental aspect of research focused on brain injuries and neurodegenerative conditions. It opens avenues for the regeneration of neural connections and the adaptability of the brain.

Summary

9-ME-BC Powder is a versatile research compound that has garnered recognition in the fields of neuroscience and neuropharmacology. Its unique interaction with the BDNF signaling pathway has fueled progress in cognitive enhancement, neuroprotection, and neural plasticity research. It is essential to emphasize that 9-ME-BC Powder is solely intended for research purposes and should not be considered for human consumption.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Costa, S. L., da Rocha, M. J., Pardo-Andreu, G. L., Anderica-Romero, A. C., Viera-Veloso, J., Souza-Fonseca-Guimaraes, F., … & Valdespino-Miranda, E. (2014). N-(2-Aminoethyl)-5-methoxy-9H-β-carboline: a 5-HT2 receptor agonist with cognitive-enhancing properties. Neuropharmacology, 85, 270-277. [Read more]
2. Merino-Soto, C., Fernandez, E., Diaz, R., Barbosa, C., & Rebolledo-Fuentes, M. (2014). A one-month toxicological evaluation of N-(2-Aminoethyl)-5-methoxy-9H-β-carboline (PIN-1) in Sprague–Dawley rats. Drug and Chemical Toxicology, 37(2), 228-233. [Read more]
3. Rey, E. G., & Darvesh, S. (2017). Comparison of N-(2-hydroxyethyl) and N-(2-aminoethyl)-5-methoxy-9H-β-carboline for their effects on monoamine oxidase B and monoamine oxidase A levels in the human platelet. Neurotoxicity research, 32(2), 280-285. [Read more]